Carbapenem resistance in Enterobacteriaceae is a growing concern worldwide ([13][1]). Resistance to carbapenems may be mediated by two mechanisms: hyperproduction of an AmpC-type cephalosporinase or extended-spectrum β-lactamase (ESBL) combined with decreased drug permeability through the outer
No takes yet. Share an insight, caveat, or question.
Naas et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: